Preparation method of saxagliptin intermediate
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 浙江四维医药科技有限公司
- Publication Date
- 2014-10-15
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical synthesis, in particular to a preparation method of a saxagliptin intermediate. Background technique
[0002] Saxagliptin, a dipeptidyl peptidase-4 (DPP4) inhibitor, is a drug developed by Bristol-Myers Squibb for the treatment of adult type II diabetes. Its structural formula is as follows:
[0003]
[0004] Saxagliptin
[0005] Under normal circumstances, saxagliptin is subjected to a condensation reaction by the following formula M and formula N compounds, such as the method disclosed in the US patent document US7223573: the condensation product is dehydrated, and the deprotection group is reacted to obtain saxagliptin,
[0006]
[0007] Among them, the main synthetic methods of the compound of formula N structure are as follows:
[0008] Route one:
[0009]
[0010] This route is the method provided in the Chinese patent with the authorization announcement number CN1213028. The SuperH...